Stockreport

Rocket Pharmaceuticals Announces Science Translational Medicine Publication of its Program in Danon Disease

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com
PDF – Results Demonstrate AAV9 Gene Therapy of LAMP2B Reverses Clinical Manifestations of Danon Disease in Mouse Study – NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals [Read more]